Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Immix Biopharma

Immix Biopharma
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
Description

Provider of clinical research and drug development services intended to develop novel and game-changing cancer therapies. The company develops new therapies and operates in the biotechnology sector, offering laboratories with cancer therapeutics such as stem cell, research and engineered antibody development.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 11150 West Olympic Boulevard
  • Los Angeles, CA 90064
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Immix Biopharma’s full profile, request a free trial.

Immix Biopharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 29-Aug-2017 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Immix Biopharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Ilya Rachman Ph.D Co-Founder & Chief Executive Officer
Ryan Witt Vice President & Chief Operating Officer
Sean Senn JD Co-Founder
Vladimir Torchilin Ph.D Co-Founder